Related Experiment Video
Updated: May 30, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Valve surgery in a mucopolysaccharidosis type I patient: early prosthetic valve endocarditis
Rodolfo V Rocha1, Rene J Alvarez, Christian A Bermudez
1Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Abstract:
Mucopolysaccharidosis (MPS) are rare genetic disorders, caused by enzymatic defects that lead to abnormal glycosaminoglycan metabolism and its accumulation. Hurler-Scheie syndrome (MPS I) is associated with a deficiency of the lysosomal enzyme α-L-iduronidase. Enzymatic replacement with intravenous laronidase is a frequently utilized therapeutic option. In patients with MPS I, progressive glycosaminoglycan storage in the heart can lead to valvular abnormalities; however, few surgical heart valve interventions have been reported in MPS I patients. We present an unusual case of a double-valve replacement in an MPS I patient, complicated by early infective endocarditis requiring surgical reintervention. We also present a comprehensive literature review of valve surgery in patients with MPS I and a brief summary of the most relevant surgical considerations, including valve selection and infection prevention.
Insights
Mucopolysaccharidosis (MPS) patients with Hurler-Scheie syndrome (MPS I) may develop heart valve issues. This case highlights complications after double-valve replacement and reviews surgical considerations for MPS I.
Area of Science:
- Cardiovascular Medicine
- Rare Genetic Disorders
- Lysosomal Storage Diseases
Background:
- Mucopolysaccharidosis (MPS) are rare genetic disorders resulting from enzyme deficiencies causing glycosaminoglycan accumulation.
- Hurler-Scheie syndrome (MPS I), a subtype of MPS, involves a deficiency in the enzyme α-L-iduronidase.
- Cardiac valvular abnormalities are a known complication of MPS I due to progressive glycosaminoglycan storage.
Observation:
- This report details an unusual case of a double-valve replacement in an MPS I patient.
- The patient experienced early infective endocarditis, necessitating surgical reintervention.
- Few surgical heart valve interventions have been documented in MPS I patients.
Findings:
- The case illustrates the potential complications, such as infective endocarditis, following valve surgery in MPS I patients.
- A comprehensive literature review on valve surgery in MPS I patients is presented.
- Key surgical considerations, including valve selection and infection prevention strategies, are summarized.
Implications:
- This study underscores the complex management of cardiac issues in MPS I patients.
- It emphasizes the need for careful surgical planning and vigilant post-operative care.
- The findings contribute to understanding and improving outcomes for valve interventions in this rare genetic disorder.
Related Concept Videos
Endocarditis I: Introduction
Mitral Stenosis III: Medical Management
Endocarditis III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management

